Medication Adherence in Hypertensive Individuals With Bipolar Disorder

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

June 4, 2018

Study Completion Date

June 28, 2018

Conditions
HypertensionBipolar Disorder
Interventions
BEHAVIORAL

iTAB-CV

"Stage 1 of the intervention will be introduced. Researchers will conduct an interview in order to customize iTAB-CV for each participant at the baseline session. In the first month, participants will receive alternating daily texts with educational and motivational content and a daily mood rating request to both monitor their mood and to determine adherence to the intervention.~In the second stage for the following month, participants will receive daily texts which will include medication reminders, contextual cues, and immediate reinforcement for medication taking behavior in addition to the content from stage 1."

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland

All Listed Sponsors
lead

Case Western Reserve University

OTHER

NCT02983877 - Medication Adherence in Hypertensive Individuals With Bipolar Disorder | Biotech Hunter | Biotech Hunter